CLASS II ONGOING Device recall · Reported 11 Jan 2023 · FDA Enforcement Report

IRISpec CA/CB/CC control recalled by Beckman Coulter

Beckman Coulter is recalling Beckman Coulter IRISpec CA/CB/CC control, distributed in Puerto Rico. The recall was initiated on 18 Nov 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 10837461002611, Lot 565-21: 11-30-2022
Quantity recalled3657 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0777-2023
FDA event ID
91175
Recalling firm
Beckman Coulter, Miami, FL
Classification
Class II
Status
Ongoing
Recall initiated
18 Nov 2022
FDA classified
3 Jan 2023
Reported
11 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 Nov 2022Recall initiated by company
3 Jan 2023Classified by FDA+46 days
11 Jan 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212

Product as listed by the FDA

BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.

Where it was distributed

US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan

Puerto Rico

Questions about this recall

Is IRISpec CA/CB/CC control recalled?

Yes. Beckman Coulter recalled IRISpec CA/CB/CC control on 18 Nov 2022. The recall is Class II and its status is Ongoing. Recall number Z-0777-2023.

Why was it recalled?

Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212

Which lots are affected?

UDI/DI 10837461002611, Lot 565-21: 11-30-2022

Where was it sold?

US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 334

Other Test Kits & Diagnostics recalls

All 2,656